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CASE REPORT Open Access
Gillespie syndrome in a South Asian child: a
case report with confirmation of a
heterozygous mutation of the ITPR1 gene
and review of the clinical and molecular
features
Daham De Silva1, Kathleen A. Williamson2, Kavinda Chandimal Dayasiri3, Nayani Suraweera3, Vinushiya Quinters3,
Hiranya Abeysekara4, Jithangi Wanigasinghe1, Deepthi De Silva5* and Harendra De Silva1
Abstract
Background: Gillespie syndrome is a rare, congenital, neurological disorder characterized by the association of
partial bilateral aniridia, non-progressive cerebellar ataxia and intellectual disability. Homozygous and heterozygous
pathogenic variants of the ITPR1 gene encoding an inositol 1, 4, 5- triphosphate- responsive calcium channel have
been identified in 13 patients recently. There have been 22 cases reported in the literature by 2016, mostly from
the western hemisphere with none reported from Sri Lanka.
Case presentation: A 10-year-old girl born to healthy non-consanguineous parents with delayed development is
described. She started walking unaided by 9 years with a significantly unsteady gait and her speech was similarly
delayed. Physical examination revealed multiple cerebellar signs. Slit lamp examination of eyes revealed bilateral
partial aniridia. Magnetic resonance imaging of brain at the age of 10 years revealed cerebellar (mainly vermian)
hypoplasia. Genetic testing confirmed the clinical suspicion and demonstrated a heterozygous pathogenic variant c.
7786_7788delAAG p.(Lys2596del) in the ITPR1 gene.
Conclusion: The report of this child with molecular confirmation of Gillespie syndrome highlights the need for
careful evaluation of ophthalmological and neurological features in patients that enables correct clinical diagnosis.
The availability of genetic testing enables more accurate counseling of the parents and patients regarding
recurrence risks to other family members.
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Background
Gillespie syndrome, also known as, aniridia-cerebellar
ataxia-intellectual disability syndrome, is a rare form of
congenital dysautonomia characterized by non-progressive
cerebellar ataxia, partial aniridia, and intellectual impair-
ment [1]. Since it was first reported in 1965 [2], there have
been 22 cases been reported worldwide by 2016 [3, 4]. Most
reports are consistent with an autosomal dominant or
recessive pattern of inheritance [5]. Identification of
homozygous or compound heterozygous recessive or de
novo heterozygous dominant pathogenic variants re-
stricted to particular domains of the inositol 1,4,5-tris-
phosphate receptor type 1 (ITPR1 gene) has confirmed
its genetic cause [3, 4, 6]. We report the first South
Asian Gillespie syndrome case with a heterozygous
pathogenic variant [c.7786_7788 del AAG p. (Lys
2596del)] of the ITPR1 gene. This new case of Gillespie
syndrome was found to carry the recurrent heterozy-
gous ITPR1 pathogenic variant c.7786_7788delAAG
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p.(Lys2596del), which has been reported in seven other
cases [3, 4, 6–8].
Case presentation
The proband is a 10-year-old Sri Lankan girl of Sinhala
ethnicity born to healthy non-consanguineous parents
with two other older, healthy sons. She had an uneventful
pregnancy and birth history and there was no family his-
tory of ophthalmological or neurological diseases. Al-
though her parents noted delayed development, they had
not sought medical attention for this. She started walking
unaided at around 9 years and continues to have a signifi-
cantly unsteady gait. Her hearing was not affected but
speech was delayed (first word at 3 years and currently
speaking 3–4-word complex sentences). Her parents re-
ported photophobia since infancy.
On examination aged 10 years, her height, weight and
occipito-frontal circumference were 132 cm (10th–25th
centile), 26 kg (25th–50th centile) and 51 cm (25th–50th
centile) respectively. She had no dysmorphic features. A
pigmented macule with a serpiginous border (22 cm×
10 cm), which may represent a blaschcoid pattern suggest-
ive of a cutaneous mosaicism, was noted on her right
thigh (Fig. 1). Neurological examination revealed an ataxic
gait, hypotonia, dysdiadochokinesia, intention tremor,
horizontal nystagmus and dysarthria, all consistent with
cerebellar disease. No pyramidal or extrapyramidal signs
were identified. She had bilateral pes planus (Fig. 2). Oph-
thalmological examination revealed her pupils to be fixed
and dilated and slit lamp examination revealed bilateral
partial aniridia (Fig. 2) with a scalloped edge of the irises,
normal fundi and impaired pupillary light reflexes.
Pupillary membrane remnants were not seen and the cor-
nea and lens were clear. Visual acuity was reduced (bilat-
eral 6/30). Intelligence Quotient (IQ) assessment revealed
moderate learning disability with better verbal IQ (verbal
comprehension, working memory and processing speed
scales) than non-verbal IQ (Test of Nonverbal Intelligence
– TONI version 3- score 70). Her short-term memory was
within normal limits although she had deficits in long-
term memory.
Magnetic resonance imaging (MRI) of the brain revealed
cerebellar hypoplasia especially affecting the vermis and
white matter changes (Fig. 3). Cervical spine x-ray, echo-
cardiogram and ultrasound abdomen were normal. Muta-
tion analysis by region-of-interest targeted sequencing
(NM_001168272.1/ENST00000302640 coding exons 46
and 52–56, which encode the region spanning Glu2094
and the entire calcium ion channel domain, respectively)
was performed as previously described [4]. This identified
a previously described pathogenic heterozygous variant in
the ITPR1 gene, namely c.7786_7788delAAG p.(Lys2596-
del). The clinically unaffected parents’ DNA have not been
tested for this variant due to lack of availability of samples.
Discussion and conclusions
Gillespie syndrome was first described in two adult siblings
who had the triad of partial aniridia, cerebellar ataxia and
oligophrenia [2]. The syndrome has since then described in
both males and females with variable ages of clinical diag-
nosis (1.5 years to 18 years) [3, 4].
Fig. 1 Right thigh with pigmented macule with a blaschcoid distribution
Fig. 2 a Close up of eyes showing bilateral partial aniridia (b) Lower
limbs with generalized wasting and pes planus
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This diagnosis needs to be considered in infants with
aniridia associated with hypotonia. Bilateral partial aniridia
is consistently seen in Gillespie syndrome. It has a charac-
teristic scalloped pupillary border, iris strands with regularly
spaced attachments to the anterior lens with some reports
of persistence of the pupillary membrane. Complete aniri-
dia, especially when associated with foveal hypoplasia, cata-
racts, corneal opacification with only rare extraocular
involvement is usually inherited as an autosomal dominant
trait; mutations of the Paired box protein 6 (PAX6) gene
are commonly implicated [9]. Contiguous gene deletions
involving PAX6 and associated with Wilms tumor, genital
abnormalities and developmental delay is recognized as the
WAGR syndrome. The PAX6 gene was studied for its pos-
sible association with Gillespie syndrome and found to be
not associated in several reports [10–12]. Other genes are
also associated with aniridia including the forkhead box C1
(FOXC1) and Paired-like homeobox transcription factor 2
(PITX2) but these are also associated with other, especially
anterior chamber anomalies.
The second major diagnostic criterion for Gillespie syn-
drome is the involvement of the brain and in particular, the
cerebellum. In early life, the majority of cases appear to
have hypotonia with marked delay in gross and fine motor
milestones being commonly reported in later infancy and
childhood [3]. Cerebellar signs reflect primary cerebellar
dysfunction and secondary disruption of the cerebro-
cerebellar anatomical circuitry. The brain MRI scan of this
child at 10-years of age revealed cerebellar atrophy and the
neurological disability was similar to most previously reported
cases [5]. There are reports of the progression of the cerebel-
lar atrophy with age although the ataxia is usually reported to
be non-progressive. In some cases, there are reports of
additional cerebral white matter abnormalities suggest-
ing the likelihood of more extensive neurological im-
pairment [13]. Psychometric assessment in this patient
confirmed moderate learning disability with better ver-
bal IQ as compared to performance IQ. Similar findings
in intellectual assessment have been reported in a re-
cently published report of Gillespie syndrome [5].
Facial dysmorphism [14], pectoral agenesis and kyphosis
are other reported manifestations [3, 4]. Bilateral pes planus
deformity was not described in previously reported children.
The genetic basis of this syndrome was defined with
identification of pathogenic variants in the inositol
1,4,5-trisphosphate receptor type 1 (ITPR1) gene on
chromosome 3p26 [3, 4]. Both biallelic homozygous or
compound heterozygous and usually de novo monoalle-
lic heterozygous ITPR1 gene pathogenic variants are
the underlying genetic defects for autosomal recessive
and dominant Gillespie syndrome respectively. The
ITPR1 gene encodes one of the three subtypes of the
inositol triphosphate (IP3)-receptor family that form
Ca2+ release channels especially in the endoplasmic
reticulum. It is also expressed in the nervous system es-
pecially the Purkinje cells of the cerebellum [15]. The
recessive pathogenic variants are predicted to cause loss
of function of the ITPR1 protein while the dominant
pathogenic variants appear to impair its function by
interacting with the normal protein complex (dominant
negative effect). The pathogenic variants are restricted
to several residues of ITPR1 in the transmembrane re-
gion of the protein involved in forming a calcium trans-
port channel. Genetic testing revealed a heterozygous,
three base pair, in frame deletion in the ITPR1 gene
namely ITPR1 c.7786_7788delAAG p. (Lys2596del) in
this child. This pathogenic variant has been previously
described in affected cases. As parental samples were
not investigated, it is uncertain if this pathogenic vari-
ant is de novo or inherited from an unaffected parent.
The ITPR1 gene has been implicated in spinocerebellar
ataxia 15 (SCA 15), an autosomal dominant, slowly
Fig. 3 MRI brain performed at 10 years of age revealing cerebellar especially vermis hypoplasia, cerebral atrophy and white matter changes
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progressive ataxia with cerebellar atrophy but no aniri-
dia. In SCA15, a milder, later onset form of cerebella
ataxia, the commonest pathogenic variant is a heterozy-
gous deletion. Early onset, non-progressive cerebellar
ataxia (SCA29), infantile onset spinocerebellar ataxia
and ataxic cerebral palsy have also been reported with
missense pathogenic variants of ITPR1 but they differ
from those in Gillespie syndrome [4].
Clinical diagnosis of Gillespie syndrome can be made
following identification of its two cardinal features of cere-
bellar ataxia and partial aniridia. All cases of aniridia re-
quire careful clinical evaluation for additional ocular and
extra-ocular features. Once suspected, targeted genetic
testing will confirm the diagnosis and enable counseling
regarding prognosis and risk of the disease in other family
members. As the parents were not planning more family,
the confirmation of a de novo pathogenic variant or inher-
itance from an unaffected parent was not pursued. This
may be required if her clinically unaffected brothers wish
to ascertain their status once they are older. Although this
child’s testing was performed free of charge, the costs of
genetic testing remain a barrier for accurate genetic diag-
nosis in patients from developing countries.
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